AQR Capital Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.55M | Buy |
425,949
+248,988
| +141% | +$906K | ﹤0.01% | 1938 |
|
|
2025
Q1 | $340K | Buy |
176,961
+20,499
| +13% | +$39.4K | ﹤0.01% | 2634 |
|
|
2024
Q4 | $297K | Buy |
156,462
+15,413
| +11% | +$29.3K | ﹤0.01% | 2497 |
|
|
2024
Q3 | $186K | Buy |
+141,049
| New | +$186K | ﹤0.01% | 2587 |
|
|
2022
Q3 | – | Sell |
-862,168
| Closed | -$304K | – | 2177 |
|
|
2022
Q2 | $304K | Buy |
862,168
+677,703
| +367% | +$239K | ﹤0.01% | 1866 |
|
|
2022
Q1 | $132K | Buy |
184,465
+102,691
| +126% | +$73.5K | ﹤0.01% | 2117 |
|
|
2021
Q4 | $185K | Buy |
81,774
+9,004
| +12% | +$20.4K | ﹤0.01% | 2100 |
|
|
2021
Q3 | $210K | Buy |
72,770
+58,751
| +419% | +$170K | ﹤0.01% | 2139 |
|
|
2021
Q2 | $53K | Sell |
14,019
-25,229
| -64% | -$95.4K | ﹤0.01% | 2208 |
|
|
2021
Q1 | $133K | Sell |
39,248
-160,845
| -80% | -$545K | ﹤0.01% | 2143 |
|
|
2020
Q4 | $560K | Sell |
200,093
-167,193
| -46% | -$468K | ﹤0.01% | 1738 |
|
|
2020
Q3 | $922K | Buy |
367,286
+138,227
| +60% | +$347K | ﹤0.01% | 1444 |
|
|
2020
Q2 | $3.11M | Buy |
229,059
+11,936
| +5% | +$162K | 0.01% | 962 |
|
|
2020
Q1 | $1.65M | Sell |
217,123
-80,356
| -27% | -$609K | ﹤0.01% | 1141 |
|
|
2019
Q4 | $1.88M | Buy |
297,479
+207,708
| +231% | +$1.31M | ﹤0.01% | 1292 |
|
|
2019
Q3 | $352K | Buy |
89,771
+78,575
| +702% | +$308K | ﹤0.01% | 1866 |
|
|
2019
Q2 | $54K | Buy |
+11,196
| New | +$54K | ﹤0.01% | 2046 |
|
|
2018
Q2 | – | Sell |
-22,622
| Closed | -$216K | – | 2314 |
|
|
2018
Q1 | $216K | Sell |
22,622
-17,209
| -43% | -$164K | ﹤0.01% | 2122 |
|
|
2017
Q4 | $592K | Sell |
39,831
-11,785
| -23% | -$175K | ﹤0.01% | 1859 |
|
|
2017
Q3 | $1.02M | Buy |
+51,616
| New | +$1.02M | ﹤0.01% | 1666 |
|